Chapter 1 examines the topics of cardiovascular anatomy and cardiac malignancy.
Cardiac Complications of Cancer Therapy
Cardiac Complications of Cancer Therapy provides you with the essentials of clinical management of the most common cardiac complications of cancer therapy. While you can find a multitude of literature on the management of cardiac problems, including both texts and journal articles, no other clinical reference book on the current market is written for nurses and midlevel providers and examines both the complexity of cardiac problems in conjunction with a cancer diagnosis.
Describing the assessment and management of common cardiac problems, chapters in this quick-reference guide examine issues such as cardiovascular anatomy, the development of cardiotoxicity and the management of cardiomyopathy in patients with cancer, targeted therapies and cardiomyopathy, acute coronary syndromes in patients with cancer, cardiac inflammatory conditions and cardiac tamponade in patients with cancer, hypertension in patients with cancer, heart failure in patients with cancer, screening and management of cardiovascular risk factors in cancer survivors, and much more.
Member Price: $76.00Nonmember Price: $104.00
Oncology Nursing Society
Chapter 2 examines anthracyclines, trastuzumab, and cardiomyopathy. Chapter 3 offers information on targeted therapies and cardiomyopathy, and Chapter 4 examines radiation therapy and the heart.
Chapter 5 reviews information on acute coronary syndromes in patients.
Chapter 6 examines cardiac inflammatory conditions and cardiac tamponade in patients with cancer.
Chapter 7 examines hypertension in patients with cancer, and Chapter 8 explores issues surrounding venous thromboembolism.
Chapter 9 examines stem cell transplantation and cardiovascular adverse events, and Chapter 10 examines heart failure in patients with cancer.
This chapter details atrial dysrhythmias and atrioventricular blocks, including electrocardiogram interpretation, atrial fibrillation, atrial flutter, supraventricular tachycardia, sick sinus syndrome, and atrioventricular blocks.
Chapter 12 details QT prolongation and antineoplastic agents and Chapter 13 examines ventricular dysrhythmias and cardiac implantable electronic devices.
Chapter 14 looks at cardiovascular evaluation of patients with cancer prior to chemotherapy and surgery, and Chapter 15 examines screening and management of cardiovascular risk factors in cancer survivors. The index is also included.